Net Net Stock Overview

Subscribe

To see hundreds more international net nets, consider subscribing

Overview

Creative Medical Technology Holdings Inc
Healthcare
P/NCAV
0.69x
Ticker
CELZ
Exchange
NASDAQ
Country
United States
Close
4.82 $
Mkt Cap
6.8M $
EV
3.3M $
NCAV Burn Rate
35.8%
Current Ratio
27.66
Debt/Equity
0.0
EV/REV
368.66x
EV/EBIT
-0.6x
EV/FCF
-0.4x
Dilution
245.4% p.A
Total Net Income
-58.2M $
Cheapness
0.0%
Creative Medical Technology Holdings, Inc. is a commercial stage biotechnology company dedicated to the advancement of identifying and translating novel biological therapeutics in the fields of immunotherapy, endocrinology, urology, neurology and orthopedics. The Company conducts substantially all of its commercial operations through its subsidiary, Creative Medical Technologies, Inc. Its products include AlloStem (CELZ-201-DDT) - allogenic human perinatal tissue derived cell program (clinical phase), ImmCelz (CELZ-100) - personalized supercharged immune therapy platform (pre-clinical trials), Type I Diabetes (CELZ-201 CREATE-1) - type I diabetes, Allostemspine Chronic Lower Back Pain (CELZ 201 ADAPT), Alova, CaverStem - erectile dysfunction treatment, FemCelz - female sexual function treatment, StemSpine - regenerative stem cell procedure for the treatment of degenerative disc disease (clinical trials), and OvaStem - stem cell therapy for premature ovarian failure.

Profitability

positive values --- Average negative values

Margins

--- Average

Valuation

positive values --- Average negative values

Dilution

--- Average